Long Acting Drug Delivery Market

Long Acting Drug Delivery Market - Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031

Long Acting Drug Delivery Market Segmented By Device and Parenteral Injections Therapies in Neurology, Oncology, Cardiovascular, Gastric, Ophthalmology Therapeutic Area

Industry: Healthcare

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Report Type: Ongoing

Report Price

$ 4900*

Pre Book
Request Report Sample

Report ID: PMRREP32863

Long Acting Drug Delivery: Overview

According to the latest research by PMR, long acting drug delivery systems are set to witness a steady-paced growth of CAGR 6.4% during the year 2021-2031.

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders.

Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.

The long acting drug delivery industry is expected to witness a rise in demand over the forecast period owing to the increasing technological advancements in clinical and pharmaceutical research globally.

What is Driving Demand for Long Acting Drug Delivery?

The long acting drug delivery systems, such as implants and injectables are responsible for a controlled delivery of API in the patient’s body. This is a major driving factor for the adoption of long acting drug delivery systems, as they reduce the burden of compliance on the patients, as compared to frequent dosing associated with traditional pills or injections.

The long acting drug delivery also reduces the metabolic degradation of the active pharmaceutical products by delivering targeted drug dosage directly into the environment or the bloodstream. The efficiency of such systems is thus responsible for driving the growth of long acting drug delivery systems worldwide.

Which factors are likely to augment growth of Long Acting Drug Delivery?

Apart from great therapeutic effects of long acting drug delivery, the main augmentative factor in this industry is the increasing value of reformulated active pharmaceutical ingredients. The key players in the industry focus on patented formulations with specified dosage forms for the therapeutic treatment of several chronic diseases.

The increasing revenue as well as a unique stance in the market over the other players has led to intensive research through competition. Companies benefit from novel formulations because of their high revenue potential. This is set to augment the growth and development of long acting drug delivery systems over the forecast period.

U.S. and Canada Long Acting Drug Delivery Outlook

The region of North America is expected to grow pose a dominant stance over the forecast period in terms of revenue share of long acting drug delivery systems. The factors aiding this growth are the presence of high profile, key players in the region, such as Lubrizol Life Science in the U.S., and innovation and development of new drug formulations.

Additionally, many companies in this region are involved in strategic partnerships for enhancement of their product portfolios through research and development activities. For instance, in June 2021, ViiV Healthcare and Halozyme Therapeutics entered a global partnership and licence agreement to leverage the latter’s ENHANZE drug delivery technology to develop ‘ultra long-acting’ drugs for human immunodeficiency virus (HIV).

Europe Demand Outlook for Long Acting Drug Delivery

The European region is expected to witness an increasing demand for long acting drug delivery systems. This is owed by the rising adoption of studies assessing the efficiency of these systems for their therapeutic effects.

For instance, long acting drug delivery implants, such as the thermoplastic polyurethanes (TPU), is used in an approved vaginal ring in Europe. It offers high levels of customization and control over drug release, creating possibilities for more efficient vaginal ring and implant designs.

Who are the Key Manufacturers and Suppliers of Long Acting Drug Delivery?

The key companies operating in manufacturing and supply of long acting drug delivery systems are

  • ViiV Healthcare
  • Halozyme Therapeutics
  • Lubrizol Life Science
  • Celanese Corporation
  • Kashiv BioSciences Inc.
  • 4P Therapeutics
  • Ipsen
  • Midatech Pharma
  • Re-Vana Therapeutics
  • Zordera
  • Creative Biolabs.

Key Segments

By Therapies

  • Device
    • Implant
    • Vaginal rings
    • Microarray patch
    • Gastric resident device
  • Parenteral Injections
    • Monoclonal antibody
    • Polymer microsphere
    • In-situ forming gel
    • Oil depot
    • Aqueous dispersion

By Therapeutic Area

  • Neurology
  • Oncology
  • Cardiovascular
  • Gastric
  • Ophthalmology
  • Others

By Distribution Channel

  • Hospital Pharmacies
    • Institutional Sales
    • Retail Sales
  • Clinical Research Institutes
  • Online Distribution Channels

By Region

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • BENELUX
    • Russia
  • South Asia
    • India
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of South Asia
  • East Asia
  • China
  • Japan
  • South Korea
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Turkey

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Long Acting Drug Delivery market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate